Separate names with a comma.
Discussion in 'Oncology' started by Anonymous, Jul 23, 2010 at 1:31 PM.
Anyone know anything about this company?
They are a lab that has developed a blood test to determine the primary tumor source. They are probably the leader in this field. Their sales leader is a fantastic guy that came from Prometheus Labs
So why haven't they filled Nashville yet. director is good guy, not sure about mgr in SE.
These test are loved by the oncologist for some reason. However a lot of Pathologists are not sold. There is another one out there as well. I dont want to name them but rumor is they are a better test.
know someone who works for the them...says hem/oncs like their test
Sales leader is a VERY good talker but doesn't always tell the truth
Manager in SE can't be counted on to bring anything to the table...just a management puppet who wants out but doesn't have what it takes to be successful.
Good product but very poor management; less than truthful to marketplace and sales teams. Recently heard that Southeast Managment just hired competitor for Southeast territory that was on performance program. Many sales people have paperwork on the street. No pressure.
Does anyone have any additional information to share about bioTheranostics?? I'm considering a move and am in the process of interviewing with them. I am fearful of making the move unless I hear some positive remarks from other sales employees.
Any help would be appreciated.
Good product but many looking to leave
I am also interviewing with the company. Any feedback from current employees? Anyone? Anything? I'd like some recent information if possible.
Good product but company losing some market to smarter competitor. CEO doesn't know what he is doing and many sales folks are trying to leave.
Whose their biggest competitor?
Test has very screwy results. US Labs, Quest, and Lab Corp all used to have test on the menu, but dropped it because of inaccurate results. Company was forced to market test on their own. Definitely look for other opportunities.
I call BS on this - test was marketed through AviaraDx before becoming bioTheranostics. Never been associated with other labs. CTID competes with TOO and Rosetta miRNA platform. All three are early stage and educating market. Time will tell who is successful